Tue.Jan 30, 2024

article thumbnail

Suppression of mast cell activation by GPR35: GPR35 is a primary target of disodium cromoglycate [Inflammation, Immunopharmacology, and Asthma]

ASPET

Mast cell stabilizers including disodium cromoglycate (DSCG) were found to have potential as the agonists of an orphan G protein-coupled receptor, GPR35, although it remains to be determined whether GPR35 is expressed in mast cells and involved in suppression of mast cell degranulation. Our purpose in this study is to verify the expression of GPR35 in mast cells, and to clarify how GPR35 modulates the degranulation.

189
189
article thumbnail

CAR-T for lupus: the ‘tip of the iceberg’ for cell therapy in autoimmune disease

BioPharma Drive: Drug Pricing

Since a landmark paper in 2022, drugmakers have begun nearly a dozen trials of cell therapies for lupus, with more set to start. Here’s why their efforts are worth watching.

Therapies 141
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Battling antibiotic resistance in the lab and the clinic

Broad Institute

Battling antibiotic resistance in the lab and the clinic By Leah Eisenstadt January 30, 2024 Breadcrumb Home Battling antibiotic resistance in the lab and the clinic Physician-scientist Roby Bhattacharyya uses genomics and his experiences treating patients to study how “superbugs” evade drugs and find better ways to combat these dangerous pathogens.

Hospitals 137
article thumbnail

ADHD Drug Zenzedi Recalled Over Pill Mixup

Drugs.com

TUESDAY, Jan. 30, 2024 -- The maker of a drug used to treat ADHD and narcolepsy has recalled one lot of the medication after a pill mixup was discovered.The recall notice, issued by Azurity Pharmaceuticals Inc., states that one lot of Zenzedi.

Drugs 138
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Selective KCNQ2/3 Potassium Channel Opener ICA-069673 Inhibits Excitability in Mouse Vagal Sensory Neurons [Neuropharmacology]

ASPET

Heightened excitability of vagal sensory neurons in inflammatory visceral diseases contributes to unproductive and difficult-to-treat neuronally based symptoms such as visceral pain and dysfunction. Identification of targets and modulators capable of regulating the excitability of vagal sensory neurons may lead to novel therapeutic options. KCNQ1-5 genes encode K V 7.1-7.5 potassium channel α-subunits.

article thumbnail

Non-opioid drug from Vertex cuts pain in major trial tests

BioPharma Drive: Drug Pricing

The company plans to soon ask the FDA for approval of the drug, which it has pitched as a safer alternative to addictive opioid painkillers.

Trials 136

More Trending

article thumbnail

Cour gets $105M, pharma help to ‘reprogram’ autoimmune disease

BioPharma Drive: Drug Pricing

Roche, Pfizer and Bristol Myers Squibb have all invested in the startup, which is using nanoparticle technology to retrain the body’s immune system.

Disease 122
article thumbnail

Build Scalable and Reliable Node.js Apps with Ease: Introducing NestJS

Perficient: Drug Development

If you’re interested in learning a robust, efficient, and scalable enterprise-level server-side framework, you’ve landed on the right blog ! We’ll start with a quick introduction, and in this post and the ones to follow, we’ll dive straight into the practical part. Together, we’ll build an application that covers various Nest JS fundamental and advanced topics, such as Services, Controllers, Modules, Repository, Pipes, Dependency Injection, and database connectivi

article thumbnail

Experimental Pain Med Could Give Patients New Option to Opioids

Drugs.com

TUESDAY, Jan. 30, 2024 -- The first new kind of pain medication in over two decades could be on the horizon for patients, with promising results announced Tuesday from a company trial. For now, the drug from Vertex Pharmaceuticals is called VX-548.

article thumbnail

Some plastic straws degrade quicker than others, new study shows

Science Daily: Pharmacology News

Not all plastics are created the same, and some last longer in the ocean than others. Scientists have been working for years to quantify the environmental lifetimes of a wide range of plastic goods to see which have the shortest and longest lifespans in the ocean. To determine what plastics persist in the ocean, the team tests different products in large tanks that recreate the natural ocean environment.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Injected Opdivo for Kidney Cancer Works Equally Well as IV Form: Study

Drugs.com

TUESDAY, Jan. 30, 2024 -- Opdivo, one of the new generation of immunotherapy cancer treatments, appears to help kidney cancer patients equally well when given as a quick injection versus the current method of intravenous delivery, a new study.

Treatment 111
article thumbnail

Prenatal substance exposure and childhood mental health

SCIENMAG: Medicine & Health

An observational study found links between prenatal substance exposure and mental health in children 10–12, but also found that controlling for environment and genetics eliminated many associations.

97
article thumbnail

U.S. Syphilis Cases Continue to Climb

Drugs.com

TUESDAY, Jan. 30, 2024 -- U.S. cases of syphilis have soared past numbers seen just a decade ago, new government statistics show. The grim numbers are for 2022, the latest year for which an accurate tally is available. More than 202,000 cases were.

article thumbnail

Revolutionizing Patent Landscaping: A Human-Supervised AI Approach to Identify Tech Clusters

Drug Patent Watch

The recent paper published in PLOS ONE presents a novel approach for efficiently retrieving a substantial number of patents related to specific technologies. The authors enhance an automated patent landscaping… The post Revolutionizing Patent Landscaping: A Human-Supervised AI Approach to Identify Tech Clusters appeared first on DrugPatentWatch - Make Better Decisions.

95
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Flame Retardant Chemicals Show Links to Preterm Birth

Drugs.com

TUESDAY, Jan. 30, 2024 -- Pregnant women exposed to flame-retardant chemicals could face an increased risk of premature birth, a new study warns.Organophosphate esters (OPEs) are commonly used as flame retardants in products like furniture, baby.

article thumbnail

How to achieve patient centricity in clinical trial listings

Antidote

Facilitating medical research relies on patient participation, yet research protocols often overlook the patient perspective. Improving patient centricity in clinical trials demands prioritizing the patient experience.

article thumbnail

Why the Rise in Breast Cancers in Younger Women?

Drugs.com

TUESDAY, Jan. 30, 2024 -- A surge in breast cancers for women younger than 50 has puzzled medical experts, but a new study provides some new information that could help halt this trend.The steady increase in diagnoses during the past two decades.

98
article thumbnail

Viral Vectors 101: Voltage Indicators

addgene Blog

Cellular communication and function depend on potential energy. Cellular activities like action potentials, muscle contractions, and the control of voltage gated ion channels all depend on transmitting and sensing electrical potential. Thankfully, there is a tool to measure these electrical events! Voltage indicators are voltmeters for cells! In this blog we will review how these indicators work, their general applications, and why viruses are essential to their use as biological tools.

Virus 88
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Ozone-Linked Deaths on the Rise Globally

Drugs.com

TUESDAY, Jan. 30, 2024 -- Deaths related to ozone air pollution will rise significantly around the world during the next two decades due to climate change, a new study warns.Cities in North America, Europe, Asia, Australia and Africa can expect to.

98
article thumbnail

KIMM develops technology for detecting injection of medication to prevent medical accidents related to analgesic drug infusion pump in hospitals

SCIENMAG: Medicine & Health

Excessive administration of analgesic drugs frequently results in medical accidents. To prevent the occurrence of these accidents, a drug infusion pump featuring a technology for safely detecting medication administration has been developed for the first time in the world.

article thumbnail

FDA Approval of Over-the-Counter Emergency Contraception Has Slashed ER Visits

Drugs.com

TUESDAY, Jan. 30, 2024 -- U.S. approval of over-the-counter emergency contraception like “Plan B” has had an unintended but positive side effect for America’s hospitals, a new study shows.Emergency room visits related to “morning-after”.

article thumbnail

Pitt receives new grant to improve opioid use disorder treatment

SCIENMAG: Medicine & Health

PITTSBURGH – The University of Pittsburgh School of Pharmacy’s Program Evaluation and Research Unit (PERU) has received a five-year, $7.8 million grant from the National Institute on Drug Abuse to improve quality of care for patients with opioid use disorder across Pennsylvania. Credit: Renee Cloutier, Ph.D.

article thumbnail

Study Confirms Link Between Smoking and ALS

Drugs.com

TUESDAY, Jan. 30, 2024 -- New research is helping confirm smoking as a risk factor for the devastating brain illness amyotrophic lateral sclerosis (ALS).

article thumbnail

Researchers find early symptoms of psychosis spectrum disorder in youth higher than expected

SCIENMAG: Medicine & Health

A new study co-led by Associate Professor Kristin Cleverley of the Lawrence Bloomberg Faculty of Nursing has found evidence that Psychosis Spectrum Symptoms (PSS) are often present in youth accessing mental health services.

Nurses 76
article thumbnail

Slip Sliding Away: Shield Yourself From Winter Injury

Drugs.com

TUESDAY, Jan. 30, 2024 -- A white winter landscape might look magical, but the cold and snow and ice can make even the simplest of tasks potentially dangerous.“It’s slip and fall season,” said Dr. Letitia Bradford, an orthopedic surgeon who.

96
article thumbnail

Peptide-Based Covalent Inhibitors Bearing Mild Electrophiles to Target a Conserved His Residue of the Bacterial Sliding Clamp

Covalent Modifiers

Guillaume Compain, Clément Monsarrat, Julie Blagojevic, Karl Brillet, Philippe Dumas, Philippe Hammann, Lauriane Kuhn, Isabelle Martiel, Sylvain Engilberge, Vincent Oliéric, Philippe Wolff, Dominique Y. Burnouf, Jérôme Wagner, and Gilles Guichard JACS Au 2024 DOI: 10.1021/jacsau.3c00572 Peptide-based covalent inhibitors targeted to nucleophilic protein residues have recently emerged as new modalities to target protein–protein interactions (PPIs) as they may provide some benefits over more classi

DNA 71
article thumbnail

Using CRISPR technology, researchers succeed in growing tomatoes that consume less water without compromising yield

Science Daily: Pharmacology News

Scientists have succeeded in cultivating and characterizing tomato varieties with higher water use efficiency without compromising yield. The researchers, employing CRISPR genetic editing technology, were able to grow tomatoes that consume less water while preserving yield, quality, and taste.

article thumbnail

Regeneron to acquire 2seventy’s cell therapy pipeline

BioPharma Drive: Drug Pricing

About 150 of the smaller company's employees will also transition to Regeneron, which is setting up a new cellular medicines research and development unit.

article thumbnail

Residents of rural ‘glades’ take a ‘leap of faith’ to combat dementia

SCIENMAG: Medicine & Health

The prevalence of Alzheimer’s disease and related dementias (ADRD) is disproportionately high among rural, racially/ethnically diverse older residents. In fact, they face up to an 80 percent greater risk of cognitive impairment in older age, and 2.5 times potentially preventable ADRD-related hospitalizations compared to urban dwellers.

article thumbnail

Gilead deepens investment in Arcus and TIGIT drugs

BioPharma Drive: Drug Pricing

The companies said the deal shows their “continued conviction in the TIGIT pathway,” an area of research that so far has not lived up to expectations.

Drugs 69
article thumbnail

New patent expiration for Becton Dickinson drug CHLORAPREP ONE-STEP

Drug Patent Watch

Annual Drug Patent Expirations for CHLORAPREP+ONE-STEP Chloraprep One-step is a drug marketed by Becton Dickinson Co and is included in two NDAs. It is available from two suppliers. There are… The post New patent expiration for Becton Dickinson drug CHLORAPREP ONE-STEP appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59
article thumbnail

Large Data Volumes (LDV) in Salesforce

Perficient: Drug Development

Aloha Trailblazers, Embarking on the journey into the vast landscape of Salesforce, this blog serves as your guide to understanding and conquering the challenges of Large Data Volumes (LDV). In the dynamic world of Salesforce, businesses encounter the complexities of managing extensive datasets. As organizations grow, navigating and optimizing performance in the face of Large Data Volumes becomes paramount.

article thumbnail

New patent for Seagen drug TUKYSA

Drug Patent Watch

Annual Drug Patent Expirations for TUKYSA Tukysa is a drug marketed by Seagen and is included in one NDA. It is available from one supplier. There are six patents protecting… The post New patent for Seagen drug TUKYSA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59